Development and Evaluation of Polyherbal Formulation for the Management of Chronic Disorder (Diabetes)
Keywords:
Polyherbal formulation, antidiabeticAbstract
Polyherbal formulation having more than one plant in the particular dosage form. These formulation shows greater therapeutic efficacy compared to single plant. In the present study it was intended to formulate antidiabetic polyherbal formulation incorporating different ratio of the Annona squamosa (leaves), Withania somnifera (roots), Tinospora cordifolia (stems)and Azadirachta indica (leaves). The seven different polyherbal formulation (HF1 to HF4) were prepared and administered orally to the streptozotocin induced diabetic rats. The experimental rats treated with the HF1 to HF4 and reference drug Glibenclamide significantly reduced the blood glucose level compared to the diabetic control group. Further, the HF1 to HF4 showed antihyperlipidemic activity by lowering the total cholesterol, triglycerides and low-density lipoprotein level as well asenhanced the high-density lipoprotein. The polyherbal formulations and reference drug improve the body wights of the rats.
References
Ahmed, S., & Khan, R. (2022). Synergistic effects of polyherbal formulations in diabetes management: A pharmacological perspective. Journal of Ethnopharmacology, 278, 114291.
Chauhan, A., Singh, P., & Kumar, A. (2022). Evaluation of antidiabetic potential of polyherbal extracts: A systematic review. Phytomedicine, 98, 153963.
Chen, Y., Zhang, H., & Li, Q. (2023). Clinical efficacy of traditional Chinese polyherbal medicine for type 2 diabetes: A meta-analysis. Frontiers in Pharmacology, 14, 1083749.
Das, S., Roy, S., & Banerjee, A. (2023). Role of bioactive compounds in polyherbal formulations for diabetes: Molecular insights and therapeutic implications. Phytotherapy Research, 37(2), 487-503.
Gupta, R., Sharma, S., & Verma, A. (2021). Polyherbal approaches for diabetes mellitus: Targeting multiple mechanisms. Pharmaceutical Biology, 59(1), 565-574.
Jain, M., Patel, A., & Shah, N. (2023). Pharmacokinetic interactions in polyherbal formulations used for diabetes management. Biomedicine & Pharmacotherapy, 157, 113963.
Khan, M., Singh, R., & Prasad, S. (2022). Antioxidant potential of polyherbal blends in mitigating diabetic complications: Experimental evidences. Free Radical Biology and Medicine, 183, 62-71.
Kumar, V., & Das, S. (2024). Nanotechnology integration in polyherbal diabetes formulations: A futuristic approach. Drug Delivery and Translational Research, 14(1), 12-26.
Kumar, V., Singh, A., & Mehta, P. (2023). Advances in polyherbal formulations for chronic metabolic diseases. Current Diabetes Reports, 23(3), 120-134.
Li, Y., Zhang, X., & Liu, W. (2023). Challenges and prospects of herbal polypharmacy in diabetes treatment: A critical review. Journal of Diabetes Research, 2023, 9862137.
Patel, S., & Shah, N. (2023). Synergistic effects of herbal combinations on glucose homeostasis: Molecular and clinical perspectives. Phytomedicine Plus, 3(1), 100231.
Patel, T., Singh, M., & Kumar, R. (2023). Meta-analysis of polyherbal formulations as adjunct therapy in diabetes. Complementary Therapies in Medicine, 70, 102936.
Reddy, K., Suresh, K., & Rao, D. (2023). Anti-inflammatory mechanisms of polyherbal extracts in diabetes-associated inflammation. Inflammopharmacology, 31(2), 359-370.
Roy, S., & Banerjee, A. (2022). Polyherbal therapy in diabetes: A comprehensive review of phytochemicals and mechanisms. Pharmacognosy Reviews, 16(31), 49-59.
Sharma, P., & Mehta, V. (2022). Standardization and quality control issues in polyherbal antidiabetic formulations. Journal of Herbal Medicine, 30, 100564.
Singh, A., & Prasad, S. (2023). Oxidative stress and polyherbal interventions in diabetes mellitus. Journal of Diabetes and Its Complications, 37(4), 108009.
Singh, R., Kumar, V., & Das, S. (2023). Emerging trends in polyherbal nanomedicine for diabetes management. Nanomedicine: Nanotechnology, Biology and Medicine, 47, 102535.
Singh, S., Verma, R., & Mehta, P. (2022). Role of phytochemicals in polyherbal formulations for diabetes treatment: An overview. Journal of Diabetes & Metabolic Disorders, 21(1), 131-145.
Suresh, K., & Rao, D. (2022). Inflammatory cytokine modulation by polyherbal extracts in diabetes: Experimental insights. Mediators of Inflammation, 2022, 2141587.
Verma, A., Gupta, R., & Sharma, S. (2022). Clinical evaluation of Ayurvedic polyherbal antidiabetic formulations: A systematic review. Evidence-Based Complementary and Alternative Medicine, 2022, 9812324.
Wang, Y., Li, H., & Chen, Z. (2023). Bioavailability enhancement strategies for polyherbal antidiabetic formulations: A pharmacokinetic review. Pharmaceutical Research, 40(5), 987-1002.
Zhang, Q., & Li, J. (2023). Effectiveness of Chinese herbal medicine combinations in type 2 diabetes mellitus: Clinical trial findings. Journal of Integrative Medicine, 21(3), 210-220.
